Viewing Study NCT05911061


Ignite Creation Date: 2025-12-24 @ 12:36 PM
Ignite Modification Date: 2025-12-30 @ 5:23 AM
Study NCT ID: NCT05911061
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-07-25
First Post: 2023-06-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase Ⅲ Clinical Trial of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell) in Booster Vaccination
Sponsor: WestVac Biopharma Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module